0001181431-11-048227.txt : 20110906 0001181431-11-048227.hdr.sgml : 20110905 20110906172536 ACCESSION NUMBER: 0001181431-11-048227 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110901 FILED AS OF DATE: 20110906 DATE AS OF CHANGE: 20110906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Norton David Y CENTRAL INDEX KEY: 0001529193 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 111076532 MAIL ADDRESS: STREET 1: ONE TOWER CENTER BLVD. CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 rrd321347.xml FORM 4 X0304 4 2011-09-01 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001529193 Norton David Y ONE TOWER CENTER BLVD. FLOOR 14 EAST BRUNSWICK NJ 08816 1 0 0 0 Common Stock, $0.01 par value 2011-09-01 4 A 0 7249 4.01 A 7249 D Option to purchase The right to receive these shares is purs 4.01 2011-09-01 4 A 0 9505 4.01 D 2011-11-26 2021-09-01 Common Stock, $0.01 par value 9505 9505 D The right to receive these shares is pursuant to a restricted stock unit grant, 100% of which shall vest 30 days from the first anniversary of the grant date. These stock options will vest as follows: 3,073 on November 26, 2011, 3,216 on February 26, 2012, and 3,216 on the earlier of May 26, 2012 or the Company's 2012 Annual Meeting of Stockholders. Irina Ishak as Attorney-In-Fact for David Y. Norton 2011-09-06